DUBLIN, July 27, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6b92mp/aptamers_market) has announced the addition of the "Aptamers Market by Type (DNA, RNA, XNA), Application (Diagnostics, Therapeutics, R&D), Technology (SELEX, Other Technologies) & by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020" report to their offering.
The global aptamers market is expected to reach $244.93 million by 2020 from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and 2020
The aptamer type segments included in this report are DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, therapeutics development, R&D, and other applications. Diagnostics applications will hold the largest share of the aptamers market in 2015. The therapeutics development application is expected to be one of the fastest-growing applications between 2015 and 2020.
The geographic segments included in this report are the Americas, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that the Americas are expected to account for the largest share in the global aptamers market in 2015. Europe is expected to register the fastest growth.
Market growth is majorly driven by the availability of R&D investments in biotechnology and pharmaceutical industries. Furthermore, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies will aid the growth of the global aptamers market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Aptamers Market, By Type
7 Aptamers Market, By Application
8 Aptamers Market, By Technology
9 Aptamers Market, By End User
10 Global Aptamers Market, By Region
11 Competitive Landscape
12 Company Profiles
- Am Biotechnologies, LLC
- Aptagen, LLC
- Aptamer Sciences Inc.
- Aptamer Solutions Ltd.
- Aptus Biotech S.L.
- Base Pair Biotechnologies, Inc.
- Neoventures Biotechnology Inc.
- Somalogic, Inc.
- Trilink Biotechnologies, Inc.
- Vivonics, Inc.
For more information visit http://www.researchandmarkets.com/research/6b92mp/aptamers_market
Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets